CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 102 enrolled
Drug / intervention
bioelectric impedance analysisprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01869777
NCT01869777N/ACompleted

Investigating the Prognostic Importance of Bioelectrical Impedance Phase Angle in Adults Treated for Newly Diagnosed Acute Leukemia

Wake Forest University Health Sciences·interventional·Posted Jun 5, 2013·Updated Aug 13, 2020

In Brief

A clinical study evaluating bioelectric impedance analysis for Acute Undifferentiated Leukemia and 10 related conditions. Completed, enrolled 102 participants across 1 site.

Detailed Summary

This clinical trial studies bioelectrical impedance measurement for predicting treatment outcome in patients with newly diagnosed acute leukemia. Diagnostic procedures, such as bioelectrical impedance measurement, may help predict a patient's response to treatment for acute leukemia.

Study Details

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 5, 2013
Enrollment StartJul 1, 2013
Primary CompletionMar 19, 2018
Study CompletionMay 1, 2020
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 13.1 years ago

Interventions

bioelectric impedance analysisprocedure

Undergo bioelectric impedance analysis